8-week study of supplement

UMIN ID: UMIN000025920

Registered date:31/01/2017

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Dry skin
• Date of first enrollment: 2017/01/31
• Target sample size: 34
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Piceatannol group: Duration: 8 weeks Test material:supplement containing piceatannol (capsules) 2 capsules per day
Placebo group: Duration: 8 weeks Test material: placebo(capsules) 2 capsules per day

Outcome(s)

• Primary Outcome: Measurement of skin condition (measurement time: 0,4,8 weeks after ingestion of supplement)
• Secondary Outcome: Visual analog scale (measurement time: 0,4,8 weeks after ingestion of supplement) SF-36v2 score (measurement time: 0,4,8 weeks after ingestion of supplement) Measurement of microflora (measurement time: 0,4 weeks after ingestion of supplement)

Key inclusion & exclusion criteria

• Age minimum: 35years-old
• Age maximum: 55years-old
• Gender: Female
• Exclude criteria: 1. Subjects who take medicine with chronic diseases. 2. Subjects with atopic dermatitis or chronic dermatitis. 3. Subjects who have possibilities for excessive sunburn. 4. Subjects who have severe allergy to foods and medicine. 5. Subjects who are pregnant or lactating, or planned to become pregnant in the near future. 6. Subjects who have a history of serious disorder. 7. Subjects who are under treatment by physician. 8. Subjects with severe anemia. 9. Subjects who have possibilities for lifestyle change during this study. 10. Subjects who have allergy to cosmetics and ingredients. 11. Subjects who are participating in other clinical studies. 12. Subjects who are judged as unsuitable for this study by the investigator.

Related Information

• Primary Sponsor: MORINAGA & CO., LTD.
• Source(s) of Monetary Support: MORINAGA & CO., LTD.